当前位置:首页 - 行情中心 - 港通医疗(301515) - 财务分析 - 现金流量表

港通医疗

(301515)

  

流通市值:13.59亿  总市值:21.56亿
流通股本:6304.16万   总股本:1.00亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金284,306,850.46138,755,526.69717,926,516.9584,915,507.84
  收到其他与经营活动有关的现金14,132,037.719,185,466.4721,933,874.9623,733,192.39
  经营活动现金流入小计298,438,888.17147,940,993.16739,860,391.86608,648,700.23
  购买商品、接受劳务支付的现金199,917,795.2694,584,672.02490,850,349.35418,439,669.49
  支付给职工以及为职工支付的现金54,937,930.1728,870,595.08143,468,816.15112,106,558.07
  支付的各项税费23,688,507.9814,646,216.7254,079,681.6339,472,648.23
  支付其他与经营活动有关的现金59,043,674.4424,930,484.6262,405,434.6453,662,226.51
  经营活动现金流出小计337,587,907.85163,031,968.44750,804,281.77623,681,102.3
  经营活动产生的现金流量净额-39,149,019.68-15,090,975.28-10,943,889.91-15,032,402.07
二、投资活动产生的现金流量:
  收回投资收到的现金326,000,00080,000,000372,000,000611,000,000
  收到的其他与投资活动有关的现金4,359,032.531,292,444.4412,727,807.378,204,157.4
  投资活动现金流入小计330,359,032.5381,292,444.44384,727,807.37619,204,157.4
  购建固定资产、无形资产和其他长期资产支付的现金8,456,996.524,512,870.3836,998,822.626,740,110.67
  投资支付的现金193,250,000191,000,000416,000,000846,000,000
  投资活动现金流出小计201,706,996.52195,512,870.38452,998,822.6872,740,110.67
  投资活动产生的现金流量净额128,652,036.01-114,220,425.94-68,271,015.23-253,535,953.27
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,000,000---
  取得借款收到的现金105,000,00096,000,000225,200,000165,200,000
  收到其他与筹资活动有关的现金6,977,971.425,991,904.7552,686,242.3827,576.91
  筹资活动现金流入小计112,977,971.42101,991,904.75277,886,242.3166,027,576.91
  偿还债务支付的现金32,800,00011,000,000184,200,000160,300,000
  分配股利、利润或偿付利息支付的现金2,728,837.441,245,667.4840,550,525.4529,108,490.41
  支付其他与筹资活动有关的现金67,972,560.8349,642,848.0938,319,916.9118,043,030.24
  筹资活动现金流出小计103,501,398.2761,888,515.57263,070,442.36207,451,520.65
  筹资活动产生的现金流量净额9,476,573.1540,103,389.1814,815,799.94-41,423,943.74
四、汇率变动对现金及现金等价物的影响-1,778.53-185.448,752.18-6,391.21
五、现金及现金等价物净增加额98,977,810.95-89,208,197.48-64,390,353.02-309,998,690.29
  加:期初现金及现金等价物余额575,872,145.5575,872,145.5640,262,498.52640,262,498.52
  期末现金及现金等价物余额674,849,956.45486,663,948.02575,872,145.5330,263,808.23
补充资料:
  净利润-9,141,458.61-14,421,866.44-
  资产减值准备21,268,758.86-48,421,782.84-
  固定资产和投资性房地产折旧3,173,640.92-4,830,279.83-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧3,173,640.92-4,830,279.83-
  无形资产摊销495,016.71-1,083,335.34-
  长期待摊费用摊销356,897.36-670,688.38-
  处置固定资产、无形资产和其他长期资产的损失-114,157.19--75,411.84-
  固定资产报废损失52,829.6-59,330.64-
  公允价值变动损失-511,856.85--957,316.41-
  财务费用3,249,072.91--5,175,679.13-
  递延所得税-3,991,655--8,798,542.32-
  其中:递延所得税资产减少-3,734,197.71--8,287,532.76-
    递延所得税负债增加-257,457.29--511,009.56-
  存货的减少-29,013,260.28-90,872,163.85-
  经营性应收项目的减少-61,157,784.26--71,797,076.69-
  经营性应付项目的增加33,377,759.14--94,072,190.26-
  其他--3,270,120.23-
  融资租入固定资产--2,749,992.25-
  现金的期末余额674,849,956.45-575,872,145.5-
  减:现金的期初余额575,872,145.5-640,262,498.52-
  现金及现金等价物的净增加额98,977,810.95--64,390,353.02-
公告日期2025-08-292025-04-212025-04-212024-10-24
审计意见(境内)标准无保留意见
TOP↑